Plus Takeda starts vaccine trial in Japan and South Korea clears Celltrion's antibody therapeutic.
The European Union has warned that it could curb exports of COVID-19 vaccines manufactured in the bloc, after a row with AstraZeneca over supplies escalated.
AstraZeneca warned at the end of last week that it was falling behind its forecast production levels
Shareholders are being offered a flat fee of $5 per share as an alternative to $3 plus a contingent value right, which could be a more attractive option if they want cash up front.
Deal Snapshot: The Danish drugmaker is partnering with GPCR drug discovery expert Septerna to develop multiple small molecules for cardiometabolic targets.
AbbVie chief commercial officer Jeffrey Stewart called Trump’s drug pricing plan a “disruption” but said ultimately the delta between US and EU drug prices may not be as high as some expect.
